InsiderTrades

Form 4 for OGN Organon & Co.

Accepted 2023-05-08 00:00:00 ET · period of report 2023-05-04 · accession 0001209191-23-028100 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-05-08 2023-05-04 OGN Milligan Sandra Head of Research, Development F - Tax $24.24 -2,168 28.6K -7% -$52.6K
D 2023-05-08 2023-05-04 OGN Milligan Sandra Head of Research, Development M - OptEx — +4,984 30.8K +19% —
D 2023-05-08 2023-05-04 OGN Milligan Sandra Head of Research, Development M - OptEx $0.00 -4,984 4,984 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-05-04 F D 2,168 $24.24 28,599 D — —
2 Common Common Stock 2023-05-04 M A 4,984 — 30,767 D — — (F1) 1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024.
3 Derivative Restricted Stock Units 2023-05-04 M D 4,984 $0.00 4,984 D — · 2023-05-04 to 2024-05-04 4,989 Common Stock (F1) 1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024.